INNOVATIVE BLOOD RESOURCES (EIN 410693869) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1947

Legal Domicile

Principal Officer

CHRISTOPHER HILLYER MD

Phone

6513327000

Tax Period

2018-04-01 to 2019-03-31

INNOVATIVE BLOOD RESOURCES, founded in 1947, is a mid-sized nonprofit that reported $62.7M in total revenue in fiscal year 2018.

Mission

SAVING LIVES BY PROVIDING BLOOD AND BIOMEDICAL SERVICES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $175,082

Program Service Revenue $62,032,032

Investment Income $493,428

Other Revenue $0

TOTAL REVENUE $62,700,542

Expense Breakdown

Grants Paid $0

Salaries & Benefits $27,826,623

Fundraising Expenses $0

Program Expenses $52,025,882

Other Expenses $34,731,281

TOTAL EXPENSES $62,557,904

Year-over-Year Comparison

	2018	2017	Change
Revenue	$62,700,542	$62,510,228	+0.0%
Expenses	$62,557,904	$61,687,989	+0.0%
Net Income	$142,638	$822,239	-0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

561

Volunteers

322

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$4,605,141

Total Directors

$3,215,937

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ELIZABETH MCQUAIL	CEO OF IBR; DIRECTOR, IBR	2.00	Officer Director	$0	$85,386	$750,607
CHRISTOPHER HILLYER MD	PRESIDENT OF IBR; DIRECTOR IBR	8.00	Officer Director	$0	$101,346	$1,791,197
MARK SCHMIDTLEIN	CHAIR, IBR	2.00	Officer Director	$0	$0	$0
BETH SHAZ MD	CHIEF MED OFFICER OF NYBC; DIRECTOR, IBR	2.00	Officer Director	$0	$71,251	$674,133
ANDREW DETLEFSEN	DIRECTOR, IBR	2.00	Director	$0	$0	$0
TIMOTHY KUCK	DIRECTOR, IBR	2.00	Director	$0	$0	$0
SCOTT LYNCH	DIRECTOR, IBR	2.00	Director	$0	$0	$0
ROBERT SCHWARTZ	DIRECTOR, IBR	1.00	Director	$0	$0	$0
JEFFREY D ALLEN	CHIEF OPERATING OFFICER	50.00	Officer	$555,180	$39,715	$594,895
JORDANA G SCHWARTZ	SECRETARY	2.00	Officer	$0	$61,082	$502,816
BERNADETTE TISO	ASSISTANT SECRETARY	2.00	Officer	$0	$49,654	$291,493
ELLEN C DISALVO	PRESIDENT NCBB DIVISION	50.00	Highest	$186,213	$0	$186,213
KATHERINE M GEIST	VP, DONOR SERVICES	50.00	Highest	$192,504	$42,994	$235,498
JED B GORLIN MD	VP, MEDICAL & QUALITY AFFAIRS	50.00	Highest	$343,468	$43,905	$387,373
MARK A JANZEN	VP, LABORATORY SERVICES	50.00	Highest	$167,336	$37,767	$205,103
NANCY L VAN BUREN MD	ASSOCIATE MEDICAL DIRECTOR	50.00	Highest	$265,601	$36,348	$301,949
DONALD C BERGLUND	FORMER CEO OF IBR	0.00		$806,366	$9,422	$815,788

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2019	$62,700,542	$62,557,904	$46,399,796	$142,638
2018	$62,510,228	$61,687,989	$46,170,837	$822,239

INNOVATIVE BLOOD RESOURCES